Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis

Elham E. Amin*, Arina J. ten Cate-Hoek, Annemieke C. Bouman, Karina Meijer, Lidwine Tick, Saskia Middeldorp, Guy Mostard, Marije ten Wolde, Simone van den Heiligenberg, Sanne van Wissen, Marlene van de Poet, Sabina Villalta, Erik Serne, Hans Martin Otten, Edith Klappe, Paolo Prandoni, Martin H. Prins, Hugo ten Cate, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E512-E519
Number of pages8
JournalThe Lancet Haematology
Volume5
Issue number11
DOIs
Publication statusPublished - Nov 2018

Keywords

  • DEEP VENOUS THROMBOSIS
  • LONG-TERM COMPLICATIONS
  • QUALITY-OF-LIFE
  • CONTROLLED-TRIAL
  • VEIN THROMBOSIS
  • STOCKINGS
  • HEALTH
  • REPLACEMENT
  • POPULATION
  • EUROQOL

Cite this

Amin, E. E., ten Cate-Hoek, A. J., Bouman, A. C., Meijer, K., Tick, L., Middeldorp, S., Mostard, G., ten Wolde, M., van den Heiligenberg, S., van Wissen, S., van de Poet, M., Villalta, S., Serne, E., Otten, H. M., Klappe, E., Prandoni, P., Prins, M. H., ten Cate, H., & Joore, M. A. (2018). Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. The Lancet Haematology , 5(11), E512-E519. https://doi.org/10.1016/S2352-3026(18)30151-0